November 16, 2017

FDA: Baxter recalls one lot of injectable amiodarone

By: Judy Mathias

Editor’s Note

The Food and Drug Administration (FDA) on November 15 announced the recall by Baxter International (Deerfield, Illinois) of one lot of Nexterone (amiodarone HCL) 150 mg/100 mL premixed injection because of the presence of particulate matter.

The particulate matter was identified as polyethylene, the primary constituent of the film and ports used to manufacture the bag in which the Nexterone is packaged.

The recalled lot (number NC109925) was distributed between August 23 and October 2, 2017.



Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

Upcoming Webinars
Live chat by BoldChat